Pharmaceutical Modeling & Simulation Services

Quotient Sciences’ modeling & simulation specialists have vast experience performing physiologically based pharmacokinetic (PBPK) modeling. They help you pinpoint the questions you need to answer and identify the data you need to collect.

Our modeling & simulation services span from early clinical development through to lifecycle management and are tailored to answer your specific needs. We work collaboratively with you and can provide long-term support to your development programs.

Industry Recognitions





Pharmaceutical Modeling & Simulation Services From Quotient Sciences

The valuable role of M&S in drug development programs is being acknowledged through increasing inclusion in global regulatory submissions. 

The complex interplay between the properties influencing your drug’s bioavailability can be described, understood, and applied in risk assessment and decision-making.  

We can provide a mechanistic understanding of the likely performance and disposition of your drug product in vivo and inform risk-based decisions on formulation and clinical design that help reduce the cost of development.  

Image
Clinical Pharmacology Services

Your partner for pharmaceutical modeling & simulation services

Join us for our next webinar
 

Perform FIH predictions

to predict fraction absorbed, maximum absorbable dose, starting dose, and potential dose range of your drug product.

Join us for our next webinar
 

Conduct quality-by-design (QbD) assessments

to assess the impact of changes to your drug product’s particle size, shape, or dissolution rate

Join us for our next webinar  
 

Predict outcomes in special populations

including pediatrics, renal or hepatic impairment, and diverse ethnicities, to better inform and conduct virtual clinical trials, such as bioequivalence assessments

Quotient Sciences Translational Pharmaceutics® platform 

Our drug product and clinical pharmacology capabilities combine into a flexible drug development and manufacturing program: Translational Pharmaceutics®

Quotient Sciences Translational Pharmaceutics® platform helps you accelerate to and through first-in-human trials and optimize formulations coming out of Phase 1 studies, with the ability to release and dose in our clinics in under seven days, adapt to emerging clinical data in real time, and more.

Contact us to learn more about the benefits of integrated Phase 1 clinical studies and drug product services with Translational Pharmaceutics®.

Image
Quotient Sciences Translational Pharmaceutics drug development platform

More insight, direct from our customers:

"Quotient Sciences has worked with us on several pediatric projects and has been very effective in translating our product concepts into successful prototype formulations."

 

 

-Testimonial from a UK-based pharmaceutical company specializing medicines for children

"Quotient Sciences has reduced our time-to-clinic and time-to-market. They understand the issues in drug development and have taken us from early stage to commercial in the most efficient way."

 

-Testimonial from a former specialty pharmaceutical company 

 

 

 

"Quotient Sciences’ expertise in improving the taste, smell, and texture of oral formulations makes them the ideal partner for our pediatric clinical programs."

 

-Testimonial from a global pharmaceutical company developing therapies for people with endocrine diseases

Small biotech

"Our small biotech company worked with Quotient Sciences on developing a complex formulation and validating the different iterations of the formulation in PK clinical studies using the Translational Pharmaceutics® approach. The project was successful, and we were generally impressed by the skillsets, professionalism, and courtesy of Quotient Sciences' scientists and other subject experts. We have also chosen to work with Quotient Sciences on two subsequent projects."

Biotech with infectious disease focus, acquired by a Fortune 50 pharma company

"Due to the low density and poor flow characteristics of our drug substance, we experienced significant blend and content uniformity issues. By transferring our program to Quotient Sciences, the development team was able to quickly produce demo batches through multiple blending steps and roller compaction using the Gerteis Mini-Pactor. The increase in drug load from 25% to 40% was a significant improvement as we prepared for future Phase II/III trials and this ultimately benefits the patients by reducing the pill burden. We have successfully manufactured several GMP batches of tablets at various doses using a common blend. Quotient Sciences is an outstanding drug development partner with a no-nonsense approach, excellent communication, speed, and robust, easy-to-review documentation, from analytical methods to master batch records." 

Former small biotech focused on oncology

"Quotient Sciences is an honest and straight-forward company with a very progressive attitude... What makes them unique is the way in which the pharmaceutical products are made on site and transferred, without leaving the building, to the clinical unit and a good, large and reliable pool of healthy volunteers." 

Clinical-stage pharmaceutical company, focused on endocrine therapies

"There is an art to the development of taste-masked oral products for pediatric indications. Quotient Sciences’ expertise in improving the taste, smell, and texture of oral formulations makes them the ideal partner for our pediatric clinical programs." 

Your partner to bring new treatments to market. Fast.

From the next generation of emerging biotechs, to Fortune 100 pharmaceutical companies, we have worked with countless companies across the pharmaceutical industry over the last 30 years. Speak with one of our experts to learn more about our capabilities and how we can help you reach your program's milestones.

Get in touch
Let’s talk about your drug program’s potential.